Global Infectious Disease In-vitro Diagnostics Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast to 2028
Infectious Disease In-vitro Diagnostics Market Growth & Trends The global infectious disease in-vitro diagnostics market size is expected to reach USD 76.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2021 to 2028. This growth is owing to factors such as the increasing prevalence of infectious diseases, the outbreak of COVID-19, growing market penetration of available treatments, and increasing consumer awareness. Diagnostics for SARS-CoV-2 detection are being continuously launched for catering to markets that have specific regulatory requirements. For instance, in September 2019, Roche launched its CE Marked antibody diagnostic test Elecsys Anti-SARS-CoV-2 S. Thus, the launch of new diagnostics is expected to lead to an increase in demand owing to their usage in the characterization of the vaccine-induced immune response, thereby boosting vaccine development. Technological advancements, such as the introduction of portable instruments like Cobas 4800 developed by Roche Diagnostics and GeneXpert by Cepheid are expected to drive market growth over the forecast period. Furthermore, increasing use of these systems to develop new tests that can detect infectious diseases is expected to fuel market growth.
Download Exclusive Sample Report (190 Pages PDF with All Related Graphs & Charts) For Free @ https://www.grandviewresearch.com/industry-analysis/ivd-infectious-diseasemarket
The launch of new products is becoming a key strategy adopted by players, as new SARSCoV-2 diagnostics are being launched by major players such as BD, bioMérieux SA, and F. Hoffmann-La Roche Ltd. For instance, in March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, and BioMedomics launched a PoC COVID-19 test that can detect antibodies in blood within 15 minutes. Infectious Disease In-vitro Diagnostics Market Report Highlights
The reagents segment dominated the overall market majorly driven by the high usage rate
The molecular diagnostics technology segment accounted for the highest revenue share in 2020. This can be attributed to the usage of PCR test for Covid-19 diagnosis
The central laboratories segment accounted for a revenue share of around 60.0% in 2020 North America accounted for the largest revenue share in 2020, driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
The market is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products
For More Insights Get FREE Detailed Sample Report @
https://www.grandviewresearch.com/industry-analysis/ivd-infectious-diseasemarket/request/rs1
Infectious Disease In-vitro Diagnostics Market Segmentation Grand View Research has segmented the global infectious disease in-vitro diagnostics market based on product, technology, application, end-use, and region: Infectious Diseases IVD Product Outlook (Revenue, USD Million, 2017 - 2028) Instruments o
MRSA
o
Streptococcus
o
Clostridium Difficile
o
VRE
o
CRE
o
Respiratory Virus
o
Candida
o
TB and Drug-resistant TB
o
Gastro-intestinal Panel Testing
o
Chlamydia
o
Gonorrhea
o
HPV
o
HIV
o
Hepatitis C
o
Hepatitis B
o
Covid-19
o
Others
Reagents
Services
o
MRSA
o
Streptococcus
o
Clostridium Difficile
o
VRE
o
CRE
o
Respiratory Virus
o
Candida
o
TB and Drug-resistant TB
o
Gastro-intestinal Panel Testing
o
Chlamydia
o
Gonorrhea
o
HPV
o
HIV
o
Hepatitis C
o
Hepatitis B
o
Covid-19
o
Others
o
MRSA
o
Streptococcus
o
Clostridium Difficile
o
VRE
o
CRE
o
Respiratory Virus
o
Candida
o
TB and Drug-resistant TB
o
Gastro-intestinal Panel Testing
o
Chlamydia
o
Gonorrhea
o
HPV
o
HIV
o
Hepatitis C
o
Hepatitis B
o
Covid-19
o
Others
Infectious Diseases IVD Technology Outlook (Revenue, USD Million, 2017 - 2028) Immunoassay
Molecular Diagnostics
Microbiology
Others
Infectious Diseases IVD Application Outlook (Revenue, USD Million, 2017 - 2028) MRSA
Streptococcus
Clostridium Difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
Covid-19
Others
Infectious Diseases IVD End-use Outlook (Revenue, USD Million, 2017 - 2028) Point of care
Central Laboratories
Others
Infectious Diseases IVD Regional Outlook (Revenue, USD Million, 2017 - 2028) North America
o
U.S.
o
Canada
o
U.K.
o
Germany
o
France
o
Italy
o
Spain
o
Japan
o
China
o
India
o
South Korea
o
Australia
Europe
Asia Pacific
Latin America o
Brazil
o
Mexico
o
Argentina
Middle East & Africa o
South Africa
o
UAE
o
Saudi Arabia
List of Key Players of Infectious Disease In-vitro Diagnostics Market BD
bioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen-Probe)
Danaher
QIAGEN
F. Hoffmann-La Roche, Ltd.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) https://www.grandviewresearch.com/inquiry/2752/ibb Interactive Kiosk Market, Interactive Kiosk, Kiosk Market, ATMs, Self-service Kiosks